169 related articles for article (PubMed ID: 33299354)
21. Synergistic activity of BET inhibitor MK-8628 and PLK inhibitor Volasertib in preclinical models of medulloblastoma.
Han Y; Lindner S; Bei Y; Garcia HD; Timme N; Althoff K; Odersky A; Schramm A; Lissat A; Künkele A; Deubzer HE; Eggert A; Schulte JH; Henssen AG
Cancer Lett; 2019 Mar; 445():24-33. PubMed ID: 30611741
[TBL] [Abstract][Full Text] [Related]
22. Reduced chromatin binding of MYC is a key effect of HDAC inhibition in MYC amplified medulloblastoma.
Ecker J; Thatikonda V; Sigismondo G; Selt F; Valinciute G; Oehme I; Müller C; Buhl JL; Ridinger J; Usta D; Qin N; van Tilburg CM; Herold-Mende C; Remke M; Sahm F; Westermann F; Kool M; Wechsler-Reya RJ; Chavez L; Krijgsveld J; Jäger N; Pfister SM; Witt O; Milde T
Neuro Oncol; 2021 Feb; 23(2):226-239. PubMed ID: 32822486
[TBL] [Abstract][Full Text] [Related]
23. Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis.
Li C; Tian Y; Liang Y; Li Q
Cancer Cell Int; 2020; 20(1):84. PubMed ID: 32190008
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma.
Veo B; Danis E; Pierce A; Wang D; Fosmire S; Sullivan KD; Joshi M; Khanal S; Dahl N; Karam S; Serkova N; Venkataraman S; Vibhakar R
Cell Rep; 2021 Apr; 35(4):109013. PubMed ID: 33910002
[TBL] [Abstract][Full Text] [Related]
25. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.
von Bueren AO; Shalaby T; Oehler-Jänne C; Arnold L; Stearns D; Eberhart CG; Arcaro A; Pruschy M; Grotzer MA
BMC Cancer; 2009 Jan; 9():10. PubMed ID: 19134217
[TBL] [Abstract][Full Text] [Related]
26. Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.
Chan TSY; Picard D; Hawkins CE; Lu M; Pfister S; Korshunov A; Roussel MF; Wechsler-Reya RJ; Henkin J; Bouffet E; Huang A
Neurooncol Adv; 2021; 3(1):vdab002. PubMed ID: 33629064
[TBL] [Abstract][Full Text] [Related]
27. Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
Bolin S; Borgenvik A; Persson CU; Sundström A; Qi J; Bradner JE; Weiss WA; Cho YJ; Weishaupt H; Swartling FJ
Oncogene; 2018 May; 37(21):2850-2862. PubMed ID: 29511348
[TBL] [Abstract][Full Text] [Related]
28. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
[TBL] [Abstract][Full Text] [Related]
29. Suppression of STAT3 NH
Ray S; Coulter DW; Gray SD; Sughroue JA; Roychoudhury S; McIntyre EM; Chaturvedi NK; Bhakat KK; Joshi SS; McGuire TR; Sharp JG
Mol Carcinog; 2018 Apr; 57(4):536-548. PubMed ID: 29280516
[TBL] [Abstract][Full Text] [Related]
30. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
[TBL] [Abstract][Full Text] [Related]
31. A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma.
Wang D; Pierce A; Veo B; Fosmire S; Danis E; Donson A; Venkataraman S; Vibhakar R
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33494392
[TBL] [Abstract][Full Text] [Related]
32. PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.
Kumar D; Jain S; Coulter DW; Joshi SS; Chaturvedi NK
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136401
[TBL] [Abstract][Full Text] [Related]
33. MiR-1284 suppresses gastric cancer progression by targeting EIF4A1.
Wei W; Cao W; Zhan Z; Yan L; Xie Y; Xiao Q
Onco Targets Ther; 2019; 12():3965-3976. PubMed ID: 31190893
[No Abstract] [Full Text] [Related]
34. Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma.
Venkataraman S; Alimova I; Balakrishnan I; Harris P; Birks DK; Griesinger A; Amani V; Cristiano B; Remke M; Taylor MD; Handler M; Foreman NK; Vibhakar R
Oncotarget; 2014 May; 5(9):2355-71. PubMed ID: 24796395
[TBL] [Abstract][Full Text] [Related]
35. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
36. Proof-of-Concept for Liquid Biopsy Disease Monitoring of
Stepien N; Senfter D; Furtner J; Haberler C; Dorfer C; Czech T; Lötsch-Gojo D; Mayr L; Hedrich C; Baumgartner A; Aliotti-Lippolis M; Schned H; Holler J; Bruckner K; Slavc I; Azizi AA; Peyrl A; Müllauer L; Madlener S; Gojo J
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173990
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.
Briel-Pump A; Beez T; Ebbert L; Remke M; Weinhold S; Sabel MC; Sorg RV
J Photochem Photobiol B; 2018 Dec; 189():298-305. PubMed ID: 30445362
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid cytokines in metastatic group 3 and 4 medulloblastoma.
Low SYY; Bte Syed Sulaiman N; Tan EEK; Ng LP; Kuick CH; Chang KTE; Tang PH; Wong RX; Looi WS; Low DCY; Seow WT
BMC Cancer; 2020 Jun; 20(1):554. PubMed ID: 32539808
[TBL] [Abstract][Full Text] [Related]
39. Phosphoglycerate dehydrogenase promotes pancreatic cancer development by interacting with eIF4A1 and eIF4E.
Ma X; Li B; Liu J; Fu Y; Luo Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):66. PubMed ID: 30744688
[TBL] [Abstract][Full Text] [Related]
40. RNA helicase EIF4A1-mediated translation is essential for the GC response.
Screen M; Matheson LS; Howden AJ; Strathdee D; Willis AE; Bushell M; Sansom O; Turner M
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 38011999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
